Gilead and Genelabs Form Hepatitis C Alliance
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 53 (Table of Contents)
Published: 4 Nov-2004
DOI: 10.3833/pdr.v2004.i53.756 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Gilead Sciences and Genelabs Technologies entered into collaboration to research, develop and commercialize novel compounds for treating hepatitis C infection...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS